GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There are several ways brokers charge. Seems strange to sign up without understanding the contract.
Your most welcome. Cheers. Little bit of info I found out from a American investor ( which me being absolutely rubbish at investing and doing research, honestly I didn’t know was that The brokers over their don’t rob people like the buggers do over here, anyway quit a few brokers are moving from charging clients and getting income via money in your account . Do not ask me how this works but it does as I’ve seen his share account ( he doesn’t know either) . Maybe you have to always have a certain amount in your account? So what’s all that crap about I here you say well it’s coming over here.
Seaking economy of words seems to be your forte. Stick with it and don't forget to DYOR.
Cheers
You could look under the fundamentals icon. ESP - 34
What do you mean by minus 34 pence. You forego your non existent siv rare among early days pharmas and we shall enjoy our nice capital gain. DYOR
I have gsk but the split could be way awaway. But the gsm board is the place to talk about them. Shear class is right. In a good share invest and forget. Timing is impossible even for professionals. Value investing is almost always the best policy. And this counter is clearly a winner.
Completely agree Fairdealer. Seaking nobody cares if you buy GSK or don’t want to buy Circassia because you can’t find out when the final results are. This is the CIR board and the general consensus both here and in the wider market is that we are significantly undervalued, so we are all very happy holding and confident that fair value (50p+) will out over the next few months.
Time in the market is almost always better than timing the market, and a lot less tiring than constantly trading shares for £360!
Why do posters write argumentative drivel, when they have clearly done NO research?
Keyboard warriors
Just bought another 401 shares in Glaxo FINAL RESULTS feb and 80p per share dividend and await split which will amount to free shares in new healthcare side. Circassia will have to wait for the time being the minus 34 p per share and no div is putting me off. Still it’s a good Penny share for the future.
It won’t be the same date as last year. Dear oh dear! You obviously haven’t a clue.
Or he could look at the financials icon above.
Here's a clue. Year end 31st December. Scroll down the RNS file where further information is available.
Any of you boffins out there know when the next financial results are due.
Will sit on my 12000 for now. Happy to wait to see next rns for China sales growth if its good then I will happily pay a higher sp to buy more. Abcam and gsk no brainers profit and divs.
Well I suppose we are all different. It works for me and that is what counts.
another massive dump occurring wonder who that is dooh
Very few do this in practice. A better adage is cut losses quickly and run profits, RUN PROFITS it is absolutely vital.
Old adage, buy on the dips sell on the highs. And never show allegiance or wet yourself over a share.
Just made a small investment in this interesting company
Assuming that the rest of the Invesco holding is purchased by Instis (the last 5% has), then I think we’re in a great spot. I’d say the combination of circumstances here are pretty rare, and the fact CIR aren’t a penny share will attract more sophisticated private investors. 46k shares is a decent holding, but no doubt there will be a number of people with >100k, so it won’t take many new buyers to move this a lot higher. I’m fascinated to see how the next 6 months unfolds!
Thanks for that breakdown. As a holder of more than your suggested example average, I was trying to find this into this morning. Hopefully very exciting times ahead!!
hTTps://m.marketscreener.com/CIRCASSIA-PHARMACEUTICALS-16012085/company/
The above link shows all current significant shareholders in CIR & has credibility as they have already added Merchant Capital’s 3.4% holding. Invesco will almost certainly decrease from 11.9% to 8.5% post the Merchant Capital share transfer.
A couple of sub 3% holders I was unaware of;
- Touchstone Innovations (now owned by IP Group) have 2.99%
- Aviva have 2.6%
- HSBC in their capacity as a market maker have 1.87%
Full listing;
R Griffiths: 28.6%
AstraZeneca - 18.9%
Invesco - 8.5%
Oryx - 8%
Lombard Odier - 5.1%
Neptune - 4.77%
Merchant Capital - 3.4%
Touchstone Innovations - 2.99%
Aviva - 2.6%
HSBC - 1.87%
Adams - 0.82%
Total : 85.55% - 321m shares
Directors :
Steven Harris - 5.95m - 1.58%
Rod Hafner - 900,544 - 0.24%
Garry Watts - 477,340 - 0.12%
F Granata - 312,500 - 0.08%
Jonathan Ems - 300,000 - 0.08%
Total : 2.11% - 7.94m
Total shares in issue:
375,189,530
Held by II’s & Director; 87.7%
PI Free float : 12.3% - 46.1m shares
For perspective, that means that just 1000 private investors with an average holding of 46k shares each could own the entire free float of Circassia. If any further II wants to try and buy in once Invesco clear then good luck to them as the price will sky rocket.